International product information

The product details shown after you switch describe the versions of Rho authorized outside the United States, including the Rho Score, which is not part of the US version.

US product information

The product details shown after you switch describe the version of Rho authorized in the United States, which reports whether a patient is Rho Positive.

Request a demo →
← All news
Company

Rho passes 150,000 patients screened in Canada

Toronto. A Mitacs feature on 16 Bit reported that Rho had screened more than 150,000 Canadian patients in routine care, flagging about 45% as possibly having low bone density, and that the company had hired two of the five Mitacs interns who worked on it.

The screening count is 16 Bit’s own figure, reported by Mitacs, the Canadian research internship organization that funded graduate interns from the University of Toronto’s applied computing program to work on Rho from 2018.

Later public figures: about 250,000 patients by December 2024 (The Globe and Mail), more than 340,000 in Canada by July 2025 (OBIO) and more than 400,000 Canadians by December 2025 (Sunnybrook Research Institute).